-
1دورية أكاديمية
المؤلفون: Grünwald, Viktor, Powles, Thomas, Masatoshi Eto, Kopyltsov, Evgeny, Sun Young Rha, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., José Méndez-Vidal, María, Sung-Hoo Hong, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Toshio Takagi, Burgents, Joseph E., Perini, Rodolfo, Cixin He, Okpara, Chinyere E., McKenzie, Jodi
المصدر: Frontiers in Oncology; 2024, p1-10, 10p
مصطلحات موضوعية: SUNITINIB, RENAL cell carcinoma, BONE metastasis, THERAPEUTICS, TREATMENT effectiveness, PROGRESSION-free survival
-
2دورية أكاديمية
المؤلفون: Grünwald, Viktor, Powles, Thomas, Masatoshi Eto, Kopyltsov, Evgeny, Sun Young Rha, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., José Méndez-Vidal, María, Sung-Hoo Hong, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Toshio Takagi, Burgents, Joseph E., Perini, Rodolfo, Cixin He, Okpara, Chinyere E., McKenzie, Jodi
المصدر: Frontiers in Oncology; 2023, p01-10, 10p
مصطلحات موضوعية: SUNITINIB, BONE metastasis, THERAPEUTICS, TREATMENT effectiveness, PROGRESSION-free survival
-
3دورية أكاديمية
المؤلفون: Gaspar, Nathalie1 (AUTHOR) nathalie.gaspar@gustaveroussy.fr, Venkatramani, Rajkumar2 (AUTHOR), Hecker-Nolting, Stefanie3 (AUTHOR), Melcon, Soledad Gallego4 (AUTHOR), Locatelli, Franco5 (AUTHOR), Bautista, Francisco6 (AUTHOR), Longhi, Alessandra7 (AUTHOR), Lervat, Cyril8 (AUTHOR), Entz-Werle, Natacha9 (AUTHOR), Casanova, Michela10 (AUTHOR), Aerts, Isabelle11 (AUTHOR), Strauss, Sandra J12 (AUTHOR), Thebaud, Estelle13 (AUTHOR), Morland, Bruce14 (AUTHOR), Nieto, Adela Cañete15 (AUTHOR), Marec-Berard, Perrine16 (AUTHOR), Gambart, Marion17 (AUTHOR), Rossig, Claudia18 (AUTHOR), Okpara, Chinyere E19 (AUTHOR), He, Cixin20 (AUTHOR)
المصدر: Lancet Oncology. Sep2021, Vol. 22 Issue 9, p1312-1321. 10p.
مصطلحات موضوعية: *DISEASE relapse, *LEUKOCYTE count, *IFOSFAMIDE, *OSTEOSARCOMA, *DRUG dosage, *NEUROECTODERMAL tumors, *THERAPEUTIC use of antineoplastic agents, *QUINOLINE, *ETOPOSIDE, *RESEARCH, *UREA, *CLINICAL trials, *PROTEIN kinase inhibitors, *RESEARCH methodology, *CANCER relapse, *MEDICAL cooperation, *EVALUATION research, *BONE tumors, *TREATMENT effectiveness, *COMPARATIVE studies, *RESEARCH funding, *KARNOFSKY Performance Status, *DRUG side effects, *DRUG resistance in cancer cells, *LONGITUDINAL method
الشركة/الكيان: MERCK & Co. Inc. 001317064 MRK